Abstract
Dysfunctional sensory systems, including altered olfactory function, have recently been reported in patients with autism spectrum disorder (ASD). Disturbances in olfactory processing can potentially result from gamma-aminobutyric acid (GABA)ergic synaptic abnormalities. The specific molecular mechanism by which GABAergic transmission affects the olfactory system in ASD remains unclear. Therefore, the present study aimed to evaluate selected components of the GABAergic system in olfactory brain regions and primary olfactory neurons isolated from Shank3-deficient (−/−) mice, which are known for their autism-like behavioral phenotype. Shank3 deficiency led to a significant reduction in GEPHYRIN/GABAAR colocalization in the piriform cortex and in primary neurons isolated from the olfactory bulb, while no change of cell morphology was observed. Gene expression analysis revealed a significant reduction in the mRNA levels of GABA transporter 1 in the olfactory bulb and Collybistin in the frontal cortex of the Shank3−/− mice compared to WT mice. A similar trend of reduction was observed in the expression of Somatostatin in the frontal cortex of Shank3−/− mice. The analysis of the expression of other GABAergic neurotransmission markers did not yield statistically significant results. Overall, it appears that Shank3 deficiency leads to changes in GABAergic synapses in the brain regions that are important for olfactory information processing, which may represent basis for understanding functional impairments in autism.
Similar content being viewed by others
Introduction
Dysfunctional sensory systems, including altered olfaction, have recently been suggested in patients with autism spectrum disorder (ASD) [1, 2]. A decrease in the amplitude and reliability of responses to odors has been reported in two mouse models of ASD [3]. Although many studies have focused on understanding the mechanisms of smell [4,5,6,7,8], the structural changes in neurite outgrowth, neuron shape, and neuronal markers associated with sensory alterations in ASD remain unclear. Olfactory nerve circuits include neurons of the olfactory bulb and their projections to the piriform cortex [8, 9]. It is also known that the olfactory bulb is characterized by the presence of many inhibitory interneurons that produce gamma-aminobutyric acid (GABA), and at the same time, different neuropeptides and neuromodulators, which undergo various neuroplastic changes during life [10, 11]. Although the classification of GABAergic neurons in the olfactory system can be based on various criteria such as their molecular markers, shape diversity, and functional properties, it is clear that interneurons make both local and long-range connections with neurons in other brain regions [12, 13]. GABAergic neurotransmission in the olfactory system involves the metabolism of GABA, transport of GABA by specific transporters, and binding of GABA to its receptors at the postsynaptic membrane [14, 15]. Dysfunction of GABAergic signaling at many levels is believed to be involved in the pathogenesis of ASD [16,17,18].
The role of potential changes in the olfactory system in ASD can be investigated using transgenic Shank3−/− (Shank3-deficient) mice that are known to have ASD-like symptoms [19, 20]. In our previous studies, we confirmed behaviors relevant to ASD in this model, and at the same time, we characterized the presence of complex changes in neurotransmission markers, including GABA [21]. Although SHANK3 proteins are primarily components of glutamatergic synapses, several studies are currently analyzing the consequences of Shank3 deficiency on GABAergic signaling in the context of ASD pathogenesis [20, 22]. One such marker is gephyrin, a scaffolding protein assembled in postsynaptic membranes that enables clustering and anchoring of GABAA receptors (GABAAR) [23]. Its interaction with GABAARs facilitates the localization of these receptors, regulating the responsiveness of neurons to GABA signaling, thus modulating inhibitory neurotransmission in the brain. The evaluation of the colocalization of gephyrin and GABAAR allows the analysis of GABAergic synaptic puncta. To the best of our knowledge, no study using the Shank3−/− mouse model of ASD has focused on GABAergic markers in the olfactory areas of the brain.
Therefore, in the present study, we hypothesized that Shank3 deficiency results in (1) altered neurite outgrowth of neurons isolated from the olfactory bulb, (2) changed expression of inhibitory GABAergic markers in the olfactory bulb, and (3) changed inhibitory GABAergic synaptic puncta in neurons isolated from the olfactory bulb and in the olfactory region of the brain cortex. The olfactory bulb and piriform cortex were selected for analysis because of their fundamental roles in initial olfactory processing. The olfactory bulb serves as the primary site for organizing and relaying olfactory input, whereas the piriform cortex contributes to further processing and interpretation before transmitting information to higher brain regions for integration.
Materials and Methods
Experimental Animals
Pairs of heterozygous knockout B6.129-Shank3tm2Gfng/J (Shank3B+/−) mice were obtained from the Jackson Laboratory (017688, JAX Laboratory, U.S.A.) and transported to the animal facility at the Faculty of Medicine of the Comenius University in Bratislava. Transgenic mouse pups were genotyped by PCR using DNA extracted from tail snips (approximately 3 mm) based on the Jackson Laboratory protocol. Only male Shank3B−/− and Shank3B+/+ homozygous (wild type (WT) control) mice were used in this study. We utilized primary neuronal cell cultures from neonatal animals and tissue samples from two distinct age groups of animals to investigate potential changes during adolescence and adulthood. The mice were housed 3–4 per cages in animal facility under controlled laboratory conditions (12:12 h light/dark cycle with lights on 06:00–18:00 h, 22 ± 2 °C, 55 ± 10% humidity) with access to a standard pelleted diet and tap water ad libitum. All experimental procedures followed the ethical guidelines for animal experiments of the European Union Council (86/609/EEC) and was approved by the Ethical Committee of the Faculty of Medicine, Comenius University in Bratislava, Slovak Republic.
Primary Cultures from Olfactory Bulb
Primary neuronal cells were isolated according to a protocol described by Reichova et al. [24]. Brains from the postnatal day 0 (P0; (3-4 pups/genotype) were dissected on ice-cold Hank’s Balanced Salt Solution –HBSS (137 mM NaCl; 5.4 mM KCl; 0.5 mM MgCl2 × 6 H2O; 0.4 mM MgCl2 × 6 H2O; 0.44 mM KH2PO4; 0.34 mM Na2HPO4 × 7 H2O; 1.25 mM CaCl2; 5.5 mM D-glucose) supplemented with 1% ATB and 0.3 M Hepes under a stereomicroscope to collect olfactory bulbs. The olfactory bulb tissues were dissociated by enzymatic treatment (HBSS, 0.1% Trypsin, 0.1 mg/ml DNAse I) for 20 min at 37 °C followed by 5 min incubation in RPMI medium (Sigma-Aldrich, Germany) containing 10% fetal bovine serum (HiClone, U.S.A.) at 37 °C. Resuspended cells were plated on 24-well plates containing glass coverslips pre-coated with 10 µg/ml Poly-D-lysine (Sigma-Aldrich, Germany) in RPMI medium containing 10% fetal bovine serum. After 3 h of cell plating, the medium was replaced with a selective growing medium, Neurobasal A (Gibco, U.S.A.), augmented with penicillin/streptomycin (100 U/ml), L-glutamine (2 mM) and B27 supplement (2% v/v; Invitrogen, U.S.A.). Primary neurons were then maintained at 37 °C in a humidified atmosphere (95% air and 5% CO2), and half of the growing medium was refreshed after 5 days in vitro (DIV5).
Immunocytochemistry
At DIV10, the medium was removed, and primary cells from the olfactory bulb were fixed with 4% paraformaldehyde for 20 min at room temperature (RT). Coverslips were blocked in PBS containing 3% NGS and 0.1% Triton X-100 for 30 min at RT. Double immunofluorescence staining was performed by incubating the cells with rabbit anti-GEPHYRIN (PA5-29036, Invitrogen, 1:500 in PBS) and chicken anti-GABAAR (224 006, Synaptic Systems, 1:500 in PBS) for 2 h at RT. The coverslips were then washed in PBS and incubated with goat anti-rabbit (Alexa Fluor 555, A21428, Sigma-Aldrich, 1:500 in PBS) and goat anti-chicken (Alexa Fluor 647, A21449, Thermo Fisher Scientific, 1:500 in PBS) for 1 h at RT. Nuclei were stained with DAPI (Thermo Fisher, 1:1000 in PBS) for 1 min. After washing in PBS, the coverslips were mounted on slides using Fluoromount-G (Sigma-Aldrich, Germany).
Tissue Processing
On P21 day, the first part of the mice (n = 9 per genotype) was sacrificed by decapitation, the brains were quickly removed from the skull, the olfactory bulbs were separated, deeply frozen in liquid nitrogen, and stored at -80 °C until RNA extraction. The second part of the adult mice (n = 6 per genotype) was deeply anesthetized with an intraperitoneal injection of sodium pentobarbital (Spofa, Czech Republic; 50 mg/kg), and immediately perfused transcardially with 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS; pH 7.4). After perfusion, the brains were dissected and post-fixed by immersion in the same fixative overnight and then infiltrated with 20% sucrose in 0.1 M PBS for 48 h at 4 °C. Finally, the brains were frozen at -20 °C and then sectioned in the coronal plane at a thickness of 30 μm with the use of a cryostat (CM1950, Leica Microsystems GmbH, Germany). The free-floating sections were collected in cold PBS (4 °C), mounted on object slides and stored at -80 °C until further processing.
Immunohistochemistry
To visualize the GEPHYRIN and GABAAR signal in the piriform cortex, selected sections (from bregma 1.18 mm to bregma 0.98 mm) in both Shank3−/− and WT mice were subjected to double immunofluorescence. Briefly, the sections were triple-washed with cold PBS and then incubated for 1 h at RT with a blocking buffer composed of 0.1 M PBS, 3% normal donkey serum (NGS), 2% bovine serum albumin (BSA) and 0.1% Triton. After this, the sections were incubated overnight at 4 °C with primary antibodies diluted in a blocking buffer (PBS containing 1% NGS, 1% BSA, and 0.4% Triton). The primary antibodies were rabbit anti-GEPHYRIN (PA5-29036, Invitrogen, 1:500) and chicken anti-GABAAR (224 006, Synaptic Systems, 1:500). The next day, the sections were rinsed in cold PBS and incubated with secondary antibodies diluted in PBS for 1.5 h at RT. The secondary antibodies were goat anti-rabbit (Alexa Fluor 555, A21428, Sigma-Aldrich, 1:500) and goat anti-chicken (Alexa Fluor 647, A21449, Thermo Fisher Scientific, 1:500). After that, the sections were washed in PBS and stained with 4′,6-Diamidin-2-phenylindol (DAPI, Thermo Fisher, 1:1000 in PBS) for 15 min. Finally, the sections were mounted with Fluoromount-G (Sigma-Aldrich, Germany) and coverslipped.
Image Acquisition
Images of fluorescent immunopositive signals were acquired using a confocal microscope (Nikon ECLIPSE Ti-E, A1R+, Netherlands) with a 40 × objective (numerical aperture 1.3; resolution 1024 × 1024 pixels) in 0.5 μm (brain sections) or 0.175 μm (primary neurons) steps. Double GEPHYRIN/GABAAR colocalization was quantified using ImageJ/Fiji software with ComDet Plugin [25]. Colocalized particles in the piriform cortex were independently detected in 274–284 regions of interest (ROI) per genotype, corresponding to 18 sections (6 parts of the bilateral piriform cortex/section, 3 ROI/each part of the piriform cortex) per genotype. Particle size was determined as 1 pixel (0,31 μm), with an intensity threshold of 3 pixels, and colocalization as a maximum distance of 1 pixel between particles. GEPHYRIN/GABAAR-positive clusters on dendrites were detected in 271–273 ROI per genotype, corresponding to 90 neuronal cells (3 ROI/cell) isolated from the olfactory bulbs per genotype. MAP2 (Microtubule-Associated Protein 2) positive cells were considered as neurons. Three coverslips per animal and at least 10 areas of interest per coverslip were evaluated. Particle size was determined as 1 pixel (0.31 μm), with an intensity threshold of 20 pixels, and colocalization as a maximum distance of 1 pixel between particles. Quantification of the longest neurite length was performed using the Fiji/ImageJ software on 98 neuronal cells isolated from the olfactory bulbs per genotype. The length of the longest neurite was quantified from the edge of the nucleus to the apical end. Based on the length of the longest neurite, the neurons were divided into 4 categories (up to 50 μm, 50–100 μm, 100–150 μm, and over 150 μm) for each genotype and analyzed the number of neurons with the longest neurite expressed as a percentage of the total measured neurons.
Quantitative Real Time PCR Analysis
Total RNA was extracted from olfactory bulb tissues using the phenol-chloroform method with TRI reagent (Molecular Research Center, Germany). The concentration and purity of RNA were determined using a Nanodrop spectrophotometer (Thermo Fisher Scientific, U.S.A.). First-strand cDNA was synthesized using a High-Capacity cDNA Reverse Transcription Kit (Thermo Fisher Scientific, U.S.A.) according to the manufacturer’s protocol. Analysis of the expression levels of selected genes was performed using PCR primers designed with Primer-Blast and Power SYBR® Green PCR Master Mix (Thermo Fisher Scientific, U.S.A.), according to the manufacturer’s instructions (sequences of specific primers in Table 1). Quantitative real-time polymerase chain reaction (qRT-PCR) was performed using a QuantStudio5 Real-Time PCR System (Thermo Fisher Scientific, U.S.A.). The thermocycling conditions were as follows: 50 °C for 2 min, 95 °C for 10 min, 50 cycles at 95 °C for 15 s, and 60 °C for 1 min. The relative differences in gene expression between the control and experimental groups were calculated using threshold cycle (CT) values that were first normalized to the housekeeping gene 18s, which served as endogenous controls in the same sample, and then relative to a control CT value using the 2−ΔΔCT method [26].
Statistical Analysis
Statistical analysis was performed using GraphPad Prism, version 8.0 (GraphPad Software Inc., CA, U.S.A.) and Excel XLSTAT plugin (XLSTAT-Premium, Addinsoft, New York, U.S.A.). The data were first tested for normal distribution using the Shapiro–Wilk test. If the data were normally distributed, the two-group means were analyzed using an unpaired two-tailed Student’s t-test. If the data distribution was not normal, the non-parametric Mann-Whitney or Kolmogorov-Smirnov test was used. Figures were generated using SigmaPlot 10.0.1 (Systat Software Inc., CA, U.S.A.). Box plots were used to report the distribution of colocalized particles and contain median, interquartile range (IQR) between the lower quartile (Q1, 25%) and the upper quartile (Q3, 75%). Data points that fell below Q1–1.5 * IQR or above Q3 + 1.5 * IQR were considered outliers and were therefore excluded from the analysis. All other data were expressed as mean ± standard deviation (SD). Statistical significance was set at p < 0.05.
Results
Primary Neurons Isolated from the Olfactory Bulb of Shank3-deficient Mice Have Reduced GABAergic Puncta
First, we determined whether Shank3 deficiency could affect neuronal morphogenesis by analyzing the length of the longest neurites. Based on the length of the longest neurite, we divided the neurons into 4 categories (up to 50 μm, 50–100 μm, 100–150 μm, and over 150 μm) for each genotype and analyzed the number of neurons with the longest neurite expressed as a percentage of the total measured neurons. Overall, we did not find changes in the longest neurites of neurons isolated from the olfactory bulb of Shank3−/− mice compared to neurons from control WT mice (Kolmogorov-Smirnov test; D = 0.1398; p = 0.3236), and the percentage of neurons with the longest neurites did not significantly differ in any length category.
To investigate whether olfactory neurons isolated from Shank3−/− mice differ in subtle synaptic changes, we evaluated GABAergic synaptic puncta. Statistical analysis revealed a significant reduction (Kolmogorov–Smirnov test; D = 0.257; p < 0.001) in GEPHYRIN/GABAAR colocalization in primary neurons isolated from the olfactory bulb of Shank3−/− mice compared to WT control neurons (Fig. 1A).
The Olfactory Areas of The Brain of Shank3 -/- Mice Have Slight Changes in Selected GABAergic Markers, and at The Same Time, Markedly Reduced GABAergic Clusters
Furthermore, we analyzed changes in the entire spectrum of GABAergic markers in the tissues of the olfactory bulb and frontal cortex (Table 2). Similar to the olfactory bulb, the frontal cortex also includes local circuits of GABAergic interneurons that are important for the regulation of cognitive and social functions in ASD [36]. For the analysis of GABAergic interneuron markers, the major transcripts for somatostatin and parvalbumin were selected. Gene expression analysis showed a significant reduction in the mRNA levels of GABA transporter 1 (Gat1) in the olfactory bulb of Shank3−/− mice compared to WT control (Mann-Whitney test; U = 47; p = 0.029). Also, expression levels of Collybistin were significantly reduced in the frontal cortex of Shank3−/− mice (Mann-Whitney test; U = 57; p = 0.046). Somatostatin expression levels showed a trend toward reduction in the frontal cortex of Shank3−/− mice, but this was not statistically significant (p = 0.059; df = 13; t = 2.16). The analysis of the expression of other GABAergic neurotransmission markers did not yield statistically significant results.
To determine whether the change in GABA transport in the olfactory system in Shank3−/− mice can have consequences on olfactory projection areas, we evaluated postsynaptic GABAergic clusters in the piriform cortex. We found a significant decrease in the colocalization of GEPHYRIN/GABAAR in the piriform cortex (Kolmogorov–Smirnov test; D = 0.199; p < 0.001) (Fig. 2A).
Discussion
Understanding the structural differences in the sensory areas of the brain of Shank3−/− mice is an important prerequisite for explaining previously described and partially known functional electrophysiological and behavioral deficits in animal models of ASD [3, 21, 37]. In this study, we found a significant reduction in specific GABAergic puncta in primary olfactory neurons in vitro, as well as in the piriform cortex in vivo. These changes correspond to a reduction in the expression of the selected GABAergic markers.
Our hypothesis that neurons isolated from the olfactory bulb of Shank3−/− mice would differ in their morphology was not confirmed. Another study, using a different model utilizing the CRISPR/Cas9 editing system for the Shank3 gene, found reduced neurite count and neurite length of neurons from inducible pluripotent stem cells reprogrammed and derived directly from patients with ASD [38]. Other authors have described different morphogenetic abnormalities (i.e., more extensively branched neurites) in Shank3 knockout neurons derived from human embryonic stem cell lines [39]. Although it has been suggested that olfactory axons display defective pathfinding in animal models of ASD [40], we did not observe any alterations in the neurite outgrowth of olfactory neurons. However, it cannot be ruled out that a specific population of olfactory neurons could show certain changes in the growth of neurites or their shape. Modification in genes related to the pathogenesis of ASD affects the growth, shape and arborization of different subtypes of neurons [24, 41, 42]. Another possibility that comes to play is that the enlarged brain volume observed in some individuals with ASD may be associated with altered neurite outgrowth and increased dendritic arborization [43, 44]. This potential overgrowth of neural connections and increased complexity in neuronal branching could contribute to the larger brain volume observed in certain cases of ASD.
Our next working hypothesis was that neurons in Shank3−/− mice would differ in subtle differences in their GABAergic synaptic connections. We found a marked reduction in GABAergic puncta in isolated primary neurons as well as in immunohistochemical sections of the piriform cortex. This finding is important because it was consistently seen in the early development stages and in samples from adult animals. Although our study did not distinguish subtypes of inhibitory interneurons, the results clearly indicate that Shank3 deficiency leads to alterations in both local and long-range GABAergic connections. Moreover, we observed a significant decrease in the gene expression of selected GABAergic markers (Gat1 and Collybistin) in the brain of Shank3−/− mice. More pronounced changes in the expression of GABAergic synapse components could be masked by homogenization of the whole tissue and the technical limits of the PCR methodology. Although not directly in the olfactory parts of the brain, other studies in Shank3−/− mice showed a reduction in the mRNA levels of GABAAR subunits or Parvalbumin in the prefrontal cortex or hippocampus [22, 45].
The concept of deficits in GABAergic signaling in ASD is not entirely new, and many data have been collected to date (e.g., [46, 47]). Our findings extend this concept to the reduction of GABA markers in the olfactory system caused by Shank3 deficiency. It is possible that impaired GABAAR-mediated synaptic transmission contributes to functional changes in smell, which should be further tested in Shank3−/− mice or other ASD animal models. Although we did not perform olfactory tests in this study, decreased interest in unfamiliar social olfactory cues was found in another ASD mouse model [48]. One possible explanation proposed by these authors is the impaired GABAAR trafficking. Alterations in the spatial arrangement of GABAergic receptors are associated with abnormal connectivity, particularly in relation to the processing of sensory information in ASD [49]. Therefore, changes in GABAergic neurotransmission were considered in the present study.
The limitations of our study include the fact that only selected areas of the olfactory system were investigated, and it is necessary to mention that further studies should focus on higher-order centers of olfactory information processing, that is, the anterior olfactory nucleus, olfactory tubercle, cortical nucleus of the amygdala, or entorhinal cortex. A second limitation is that we could not directly compare individual developmental stages, since we did not evaluate all their parameters. A third limitation is the lack of behavioral olfactory sensitivity testing, which could be functionally altered, however, this assumption in connection with inhibitory neurotransmission requires further testing.
In conclusion, our findings on the reduction of GABAergic synapse components are important for clarifying the pathological implications of Shank3 deficiency. In a wider context, the results of the present study contribute to the knowledge of GABArgic abnormalities in ASD-like conditions, which can manifest as impairments in the olfactory system.
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Sweigert JR, St John T, Begay KK, Davis GE, Munson J, Shankland E, Estes A, Dager SR, Kleinhans NM (2020) Characterizing olfactory function in children with Autism Spectrum disorder and children with sensory Processing Dysfunction. Brain Sci 10(6):362. https://doi.org/10.3390/brainsci10060362
Boudjarane MA, Grandgeorge M, Marianowski R, Misery L, Lemonnier É (2017) Perception of odors and tastes in autism spectrum disorders: a systematic review of assessments. Autism Res 10(6):1045–1057. https://doi.org/10.1002/aur.1760
Geramita MA, Wen JA, Rannals MD, Urban NN (2020) Decreased amplitude and reliability of odor-evoked responses in two mouse models of autism. J Neurophysiol 123(4):1283–1294. https://doi.org/10.1152/jn.00277.2019
McClard CK, Kochukov MY, Herman I, Liu Z, Eblimit A, Moayedi Y, Ortiz-Guzman J, Colchado D, Pekarek B, Panneerselvam S, Mardon G, Arenkiel BR (2018) POU6f1 mediates neuropeptide-dependent plasticity in the adult brain. J Neurosci 38(6):1443–1461. https://doi.org/10.1523/JNEUROSCI.1641-17.2017
Boesveldt S, Parma V (2021) The importance of the olfactory system in human well-being, through nutrition and social behavior. Cell Tissue Res 383(1):559–567. https://doi.org/10.1007/s00441-020-03367-7
Gottfried JA (2010) Central mechanisms of odour object perception. Nat Rev Neurosci 11(9):628–641. https://doi.org/10.1038/nrn2883
Zhou G, Lane G, Cooper SL, Kahnt T, Zelano C (2019) Characterizing functional pathways of the human olfactory system. Elife 8:e47177. https://doi.org/10.7554/eLife.47177
Chen Y, Chen X, Baserdem B, Zhan H, Li Y, Davis MB, Kebschull JM, Zador AM, Koulakov AA, Albeanu DF (2022) High-throughput sequencing of single neuron projections reveals spatial organization in the olfactory cortex. Cell 185(22):4117–4134e28. https://doi.org/10.1016/j.cell.2022.09.038
Imamura F, Ito A, LaFever BJ (2020) Subpopulations of projection neurons in the olfactory bulb. Front Neural Circuits 14:561822. https://doi.org/10.3389/fncir.2020.561822
Huang L, Ung K, Garcia I, Quast KB, Cordiner K, Saggau P, Arenkiel BR (2016) Task Learning promotes plasticity of Interneuron Connectivity Maps in the olfactory bulb. J Neurosci 36(34):8856–8871. https://doi.org/10.1523/JNEUROSCI.0794-16.2016
Brunert D, Rothermel M (2021) Extrinsic neuromodulation in the rodent olfactory bulb. Cell Tissue Res 383(1):507–524. https://doi.org/10.1007/s00441-020-03365-9
Tepe B, Hill MC, Pekarek BT, Hunt PJ, Martin TJ, Martin JF, Arenkiel BR (2018) Single-cell RNA-Seq of mouse olfactory bulb reveals Cellular Heterogeneity and Activity-Dependent Molecular Census of Adult-born neurons. Cell Rep 25(10):2689–2703e3. https://doi.org/10.1016/j.celrep.2018.11.034
Villar PS, Hu R, Araneda RC (2021) Long-range GABAergic inhibition modulates Spatiotemporal Dynamics of the output neurons in the olfactory bulb. J Neurosci 41(16):3610–3621. https://doi.org/10.1523/JNEUROSCI.1498-20.2021
Fritschy JM, Brünig I (2003) Formation and plasticity of GABAergic synapses: physiological mechanisms and pathophysiological implications. Pharmacol Ther 98(3):299–323. https://doi.org/10.1016/s0163-7258(03)00037-8
Roth FC, Draguhn A (2012) GABA metabolism and transport: effects on synaptic efficacy. Neural Plast 2012:805830. https://doi.org/10.1155/2012/805830
Tyzio R, Nardou R, Ferrari DC, Tsintsadze T, Shahrokhi A, Eftekhari S, Khalilov I, Tsintsadze V, Brouchoud C, Chazal G, Lemonnier E, Lozovaya N, Burnashev N, Ben-Ari Y (2014) Oxytocin-mediated GABA inhibition during delivery attenuates autism pathogenesis in rodent offspring. Science 343(6171):675–679. https://doi.org/10.1126/science.1247190
Zhao H, Mao X, Zhu C, Zou X, Peng F, Yang W, Li B, Li G, Ge T, Cui R (2021) GABAergic System Dysfunction in Autism Spectrum disorders. Front Cell Dev Biol 9:781327. https://doi.org/10.3389/fcell.2021.781327
Hollestein V, Poelmans G, Forde NJ et al (2023) Excitatory/inhibitory imbalance in autism: the role of glutamate and GABA gene-sets in symptoms and cortical brain structure. Transl Psychiatry 13:18. https://doi.org/10.1038/s41398-023-02317-5
Peça J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN, Lascola CD, Fu Z, Feng G (2011) Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472(7344):437–442. https://doi.org/10.1038/nature09965
Chen Q, Deister CA, Gao X, Guo B, Lynn-Jones T, Chen N, Wells MF, Liu R, Goard MJ, Dimidschstein J, Feng S, Shi Y, Liao W, Lu Z, Fishell G, Moore CI, Feng G (2020) Dysfunction of cortical GABAergic neurons leads to sensory hyper-reactivity in a Shank3 mouse model of ASD. Nat Neurosci 23(4):520–532. https://doi.org/10.1038/s41593-020-0598-6
Bukatova S, Renczes E, Reichova A, Filo J, Sadlonova A, Mravec B, Ostatnikova D, Bakos J, Bacova Z (2021) Shank3 Deficiency is Associated with altered Profile of neurotransmission markers in pups and adult mice. Neurochem Res 46(12):3342–3355. https://doi.org/10.1007/s11064-021-03435-6
Filice F, Vorckel KJ, Sungur AO, Wohr M, Schwaller B (2016) Reduction in parvalbumin expression not loss of the parvalbumin-expressing GABA interneuron subpopulation in genetic parvalbumin and shank mouse models of autism. Mol Brain 9:10. https://doi.org/10.1186/s13041-016-0192-8
Liu YT, Tao CL, Zhang X, Xia W, Shi DQ, Qi L, Xu C, Sun R, Li XW, Lau PM, Zhou ZH, Bi GQ (2020) Mesophasic organization of GABAA receptors in hippocampal inhibitory synapses. Nat Neurosci 23(12):1589–1596. https://doi.org/10.1038/s41593-020-00729-w
Reichova A, Bacova Z, Bukatova S, Kokavcova M, Meliskova V, Frimmel K, Ostatnikova D, Bakos J (2020) Abnormal neuronal morphology and altered synaptic proteins are restored by oxytocin in autism-related SHANK3 deficient model. Mol Cell Endocrinol 518:110924. https://doi.org/10.1016/j.mce.2020.110924
Bottermann M, Foss S, Caddy SL et al (2019) Complement C4 prevents viral infection through Capsid inactivation. Cell Host Microbe 25(4):617–629e7. https://doi.org/10.1016/j.chom.2019.02.016
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4):402–408. https://doi.org/10.1006/meth.2001.1262
Shen J, Wang C, Ying J, Xu T, McAlinden A, O’Keefe RJ (2019) Inhibition of 4-aminobutyrate aminotransferase protects against injury-induced osteoarthritis in mice. JCI Insight 4(18):e128568. https://doi.org/10.1172/jci.insight.128568
Liu Z, Sin KWT, Ding H, Doan HA, Gao S, Miao H, Wei Y, Wang Y, Zhang G, Li YP (2018) p38β MAPK mediates ULK1-dependent induction of autophagy in skeletal muscle of tumor-bearing mice. Cell Stress 2(11):311–324. https://doi.org/10.15698/cst2018.11.163
Yang Y, Chen M, Zhai Z, Dai Y, Gu H, Zhou X, Hong J (2021) Long non-coding RNAs Gabarapl2 and Chrnb2 positively regulate Inflammatory Signaling in a mouse model of Dry Eye. Front Med (Lausanne) 8:808940. https://doi.org/10.3389/fmed.2021.808940
Provenzano G, Gilardoni A, Maggia M, Pernigo M, Sgadò P, Casarosa S, Bozzi Y (2020) Altered expression of GABAergic markers in the Forebrain of Young and Adult Engrailed-2 knockout mice. Genes (Basel) 11(4):384. https://doi.org/10.3390/genes11040384
Du Z, Tertrais M, Courtand G, Leste-Lasserre T, Cardoit L, Masmejean F, Halgand C, Cho YH, Garret M (2017) Differential Alteration in expression of Striatal GABAAR subunits in Mouse models of Huntington’s Disease. Front Mol Neurosci 10:198. https://doi.org/10.3389/fnmol.2017.00198
Rowley NM, Smith MD, Lamb JG, Schousboe A, White HS (2011) Hippocampal betaine/GABA transporter mRNA expression is not regulated by inflammation or dehydration post-status epilepticus. J Neurochem 117(1):82–90. https://doi.org/10.1111/j.1471-4159.2011.07174.x
Hasel P, Dando O, Jiwaji Z et al (2017) Neurons and neuronal activity control gene expression in astrocytes to regulate their development and metabolism. Nat Commun 8:15132. https://doi.org/10.1038/ncomms15132
Shikanai H, Yoshida T, Konno K, Yamasaki M, Izumi T, Ohmura Y, Watanabe M, Yoshioka M (2012) Distinct neurochemical and functional properties of GAD67-containing 5-HT neurons in the rat dorsal raphe nucleus. J Neurosci 32(41):14415–14426. https://doi.org/10.1523/JNEUROSCI.5929-11.2012
Takahashi M, Haraguchi A, Tahara Y, Aoki N, Fukazawa M, Tanisawa K, Ito T, Nakaoka T, Higuchi M, Shibata S (2017) Positive association between physical activity and PER3 expression in older adults. Sci Rep 7:39771. https://doi.org/10.1038/srep39771
Yan Z, Rein B (2022) Mechanisms of synaptic transmission dysregulation in the prefrontal cortex: pathophysiological implications. Mol Psychiatry 27(1):445–465. https://doi.org/10.1038/s41380-021-01092-3
Kuruppath P, Xue L, Pouille F, Jones ST, Schoppa NE (2023) Hyperexcitability in the olfactory bulb and impaired fine odor discrimination in the Fmr1 KO mouse model of fragile X syndrome. bioRxiv [Preprint]. 10. 2023.04.10.536251
Rao SR, Kostic A, Baillargeon P, Fernandez-Vega V, de Anda MR, Fletcher K, Shumate J, Scampavia L, Buxbaum JD, Spicer TP (2022) Screening for modulators of autism spectrum disorder using induced human neurons. SLAS Discov 27(2):128–139. https://doi.org/10.1016/j.slasd.2022.01.004
Kathuria A, Nowosiad P, Jagasia R, Aigner S, Taylor RD, Andreae LC, Gatford NJF, Lucchesi W, Srivastava DP, Price J (2018) Stem cell-derived neurons from autistic individuals with SHANK3 mutation show morphogenetic abnormalities during early development. Mol Psychiatry 23(3):735–746. https://doi.org/10.1038/mp.2017.185
Palmer AM, Degano AL, Park MJ, Ramamurthy S, Ronnett GV (2011) Normal mitral cell dendritic development in the setting of Mecp2 mutation. Neuroscience 202:108–116. https://doi.org/10.1016/j.neuroscience.2011.11.044
Reichova A, Schaller F, Bukatova S, Bacova Z, Muscatelli F, Bakos J (2021) The impact of oxytocin on neurite outgrowth and synaptic proteins in Magel2-deficient mice. Dev Neurobiol 81(4):366–388. https://doi.org/10.1002/dneu.22815
Shyamasundar S, Ramya S, Kandilya D, Srinivasan DK, Bay BH, Ansari SA, Dheen ST (2023) Maternal diabetes deregulates the expression of Mecp2 via miR-26b-5p in mouse embryonic neural stem cells. Cells 12(11):1516. https://doi.org/10.3390/cells12111516
Courchesne E, Pierce K (2005) Brain overgrowth in autism during a critical time in development: implications for frontal pyramidal neuron and interneuron development and connectivity. Int J Dev Neurosci 23(2–3):153–170. https://doi.org/10.1016/j.ijdevneu.2005.01.003
Falougy HE, Filova B, Ostatnikova D, Bacova Z, Bakos J (2019) Neuronal morphology alterations in autism and possible role of oxytocin. Endocr Regul 53(1):46–54. https://doi.org/10.2478/enr-2019-0006
Tabouy L, Getselter D, Ziv O et al (2018) Dysbiosis of microbiome and probiotic treatment in a genetic model of autism spectrum disorders. Brain Behav Immun 73:310–319. https://doi.org/10.1016/j.bbi.2018.05.015
Pizzarelli R, Cherubini E (2011) Alterations of GABAergic signaling in autism spectrum disorders. Neural Plast 2011:297153. https://doi.org/10.1155/2011/297153
Pagano J, Landi S, Stefanoni A et al (2023) Shank3 deletion in PV neurons is associated with abnormal behaviors and neuronal functions that are rescued by increasing GABAergic signaling. Mol Autism 14(1):28. https://doi.org/10.1186/s13229-023-00557-2
Nakamura T, Arima-Yoshida F, Sakaue F et al (2016) PX-RICS-deficient mice mimic autism spectrum disorder in Jacobsen syndrome through impaired GABAA receptor trafficking. Nat Commun 7:10861. https://doi.org/10.1038/ncomms10861
Babij R, Ferrer C, Donatelle A et al (2023) Gabrb3 is required for the functional integration of pyramidal neuron subtypes in the somatosensory cortex. Neuron 111(2):256–274e10. https://doi.org/10.1016/j.neuron.2022.10.037
Acknowledgements
This work was supported by projects 2/0148/21 and 2/0057/23 of the Grant Agency of the Ministry of Education and Slovak Academy of Sciences (VEGA) and by the Slovak Research and Development Agency projects APVV-21-0189 and APVV-20-0114.
Funding
Open access funding provided by The Ministry of Education, Science, Research and Sport of the Slovak Republic in cooperation with Centre for Scientific and Technical Information of the Slovak Republic
Author information
Authors and Affiliations
Contributions
All authors had full access to all the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Conceptualization: J.B.; Investigation: D.M.; V.B.; Z.P.; Z.B.; J.B.; Resources: V.B.; D.O.; Z.B., J.B.; Writing - Original Draft: D.M.; J.B.; Writing - Review & Editing: D.M., D.O., Z.B; J.B.; Funding Acquisition: D.O.; Z.B.; J.B.
Corresponding author
Ethics declarations
Conflict of Interest
Authors declare no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Mihalj, D., Borbelyova, V., Pirnik, Z. et al. Shank3 Deficiency Results in a Reduction in GABAergic Postsynaptic Puncta in the Olfactory Brain Areas. Neurochem Res 49, 1008–1016 (2024). https://doi.org/10.1007/s11064-023-04097-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11064-023-04097-2